A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
about
Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytesInsulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysCellular ageing mechanisms in osteoarthritisHuman conditions of insulin-like growth factor-I (IGF-I) deficiencyFunctional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancersMultiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaInsulin-like growth factor system in cancer: novel targeted therapiesMolecular cloning, bioinformatics analysis and expression of insulin-like growth factor 2 from Tianzhu white yak, Bos grunniensSerum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this TechnologySmall is beautiful: insulin-like growth factors and their role in growth, development, and cancerApplication of insulin-like growth factor-1 in the treatment of inner ear disordersUpregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilageBiological effects of growth hormone on carbohydrate and lipid metabolism.The GH/IGF-1 Axis and Heart Failure.The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesDeletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humansInsulin-like growth factor 1 (IGF-1): a growth hormoneInhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachGrowth and maintenance of HeLa cells in serum-free medium supplemented with hormonesSuppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardationEffect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretionDifferential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo.Dual control of cell growth by somatomedins and platelet-derived growth factorComparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.Acromegaly update--etiology, diagnosis and management.The role of abnormal hemorrheodynamics in the pathogenesis of diabetic retinopathy.The quantitative and functional relation between insulin-like growth factor-I (IGF) and IGF-binding proteins during human osteoarthritis.Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.Radioimmunoassay of somatomedin B. Application to clinical and physiologic studies.Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cellsGene regulation by growth hormone.Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissuesCompetitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes.Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage.Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty.Enhancement of somatomedin titers of normal and hypopituitary sera by addition of L-triiodothyronone in vitro at physiological concentrations
P2860
Q24796505-8AD8175E-84A6-4887-8AA0-E765CAC08792Q26742114-E97CE3DD-5491-4B41-B2B7-6FCA70587C76Q26746549-40A2142C-CE53-4577-988C-8735F1D9A0A6Q26822806-94440FB6-55CD-404C-BCA6-B0F5EF8265C9Q26830002-11E349A6-2F1E-4757-A842-A5F94632126BQ28076524-93A3AD99-D84A-4AA8-AFAD-D39E526CBC76Q28080514-1722B0CE-20D1-45DC-9E7D-05E8A992801BQ28081603-75140542-201A-4A33-BA97-39E3B5715925Q28659681-B137960F-0EE6-4692-9CE8-EEABFAF1D744Q28817809-C3414657-DC3B-4942-8AAB-8C9E5E8A38F7Q30395770-F219FC6E-80E4-46B9-99AF-B34343A9715CQ30428706-D6DD8151-C9CA-47C9-BF10-5FE2077209F8Q33564495-31D709FB-7174-46BD-BC48-9837F862E203Q33625416-B4513911-DCB3-43D3-B1C8-4B3733650BC6Q33654009-5A01DE15-E37C-4CD8-AC2C-075E17840A0EQ33658023-42B6A819-36D7-4086-B0C3-A2474F2D960FQ33735931-874374F4-2BDA-465E-A0A8-94A5954E62E9Q33907536-D6BA5E7F-BC6A-497E-8F4E-61A42F7E420DQ33918809-BA90C629-701D-4E20-82F3-C62B5F759F1BQ33925323-5D739A64-4F61-49C8-A631-DD686C797CA6Q33962686-E08D0940-41BD-4C56-B64E-920B72AB909CQ33988934-CF7721DC-CB89-4C40-AC5A-5BCDED689C43Q34043294-3B4E8B5D-CD04-47A2-8C5C-1E3B662AD472Q34046618-6C2A5B8A-D5CF-4B1C-94A1-FBB977D97B4FQ34131991-94C05290-B883-41A1-9199-01C2BED84D32Q34166887-ED076495-AC3D-4DE2-B764-5307B22DE0EFQ34184378-A7DA8F8E-2164-44E5-B4C5-30F93653680AQ34195293-0E3F7236-7EFF-401E-A826-27800D406EB6Q34209242-28D05012-9041-4C53-9838-EF0BB5404677Q34334367-824364A9-D5CE-431D-84A3-64436ECE0279Q34422481-012C8948-D505-4ACA-B28D-B0719AD6CBEBQ34439541-45C42A72-3C90-4431-9AF5-5EBE66B93766Q34472388-2FBB664F-8BAA-42FF-914A-F3E6B522E25FQ34559166-C3FE38CF-AE03-42B7-985F-1D6C470875DFQ34574197-C265A9BE-7C60-4651-84B8-094D36610150Q34605361-10D9A2FD-8F65-4162-864C-3B207714D0F5Q34723347-CDEDC58C-674A-4E92-B9EE-5C27AE4F98ACQ35018855-87089327-819A-4352-85D3-A8040D76EA97Q35052389-806E5359-10B0-4717-8487-9C0E9F687499Q35070016-9A979FD6-15C6-4751-94C8-FE129F7DFFF1
P2860
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
description
1957 nî lūn-bûn
@nan
1957 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1957 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1957年の論文
@ja
1957年論文
@yue
1957年論文
@zh-hant
1957年論文
@zh-hk
1957年論文
@zh-mo
1957年論文
@zh-tw
1957年论文
@wuu
name
A hormonally controlled serum ...... oration by cartilage in vitro.
@ast
A hormonally controlled serum ...... oration by cartilage in vitro.
@en
A hormonally controlled serum ...... oration by cartilage in vitro.
@nl
type
label
A hormonally controlled serum ...... oration by cartilage in vitro.
@ast
A hormonally controlled serum ...... oration by cartilage in vitro.
@en
A hormonally controlled serum ...... oration by cartilage in vitro.
@nl
prefLabel
A hormonally controlled serum ...... oration by cartilage in vitro.
@ast
A hormonally controlled serum ...... oration by cartilage in vitro.
@en
A hormonally controlled serum ...... oration by cartilage in vitro.
@nl
P1476
A hormonally controlled serum ...... poration by cartilage in vitro
@en
P2093
W D SALMON
W H DAUGHADAY
P304
P577
1957-06-01T00:00:00Z